Experimental data on ischemic stroke, neonatal hypoxic-ischemic encephalopathy, epilepsy and Alzheimer’s disease indicated that secretoneurin may functionally act as a brain-protective factor [8–11]. This evidence concerns the gene SCG2 and Alzheimer disease.